Suppr超能文献

掌跖脓疱病和慢性湿疹性手部皮炎。治疗、表皮朗格汉斯细胞以及与甲状腺疾病的关联。

Pustulosis palmoplantaris and chronic eczematous hand dermatitis. Treatment, epidermal Langerhans cells and association with thyroid disease.

作者信息

Rosén K

机构信息

Department of Dermatology, University of Göteborg, Sweden.

出版信息

Acta Derm Venereol Suppl (Stockh). 1988;137:1-52.

PMID:3285630
Abstract

Long-standing hand and foot dermatoses, e.g. pustulosis palmoplantaris (PPP) and chronic eczematous hand dermatitis, severely affect the patients' quality of life. The cause of PPP is unknown and the disease usually responds unsatisfactorily to treatment. The aims of the studies of PPP were to determine the prevalence of thyroid disease and to evaluate the relative merits of treatment with etretinate, psoralen photochemotherapy (PUVA), and a combination of the two. Furthermore, epidermal Langerhans cells (LC) were quantified in lesional skin before and after treatment. The prevalence of thyroid disease was significantly increased in a group of PPP patients compared to normal individuals and psoriasis patients. Both hypo and hyperthyroidism were found. In addition, circulating autoantibodies to thyroid antigens were more common in patients with PPP than in the control group. The thyroid status was further examined in a new and larger group of PPP patients, including a 4-year follow-up examination of those with thyroid antibodies or subclinical thyroid dysfunction. The increased prevalence of thyroid diseases was corroborated when this PPP group was compared to an age and sex-matched control population sample from the same city. Some patients also showed biochemical evidence of gastric autoimmunity. Ninetyfour percent of the PPP patients were smokers at the time of onset of the skin disease, compared to 33% of the subjects in a control group. Patients with treatment-resistant PPP were recruited for a randomised, double-blind and placebo-controlled trial. A combination of etretinate and PUVA was more effective than monotherapy with etretinate or PUVA. The latter were equally effective. Etretinate frequently provoked side effects. Follow-up examinations showed a high relapse rate. Epidermal LC were visualised with monoclonal antibodies to Leu 6 and HLA-DR antigens utilizing an immunoperoxidase technique. Their number was increased in lesional skin. The number of HLA-DR positive LC was decreased following etretinate, and normalised with etretinate + PUVA. Chronic eczematous hand dermatitis is a common clinical challenge. These studies aimed at an evaluation of PUVA and UVB phototherapy in patients with recalcitrant lesions and to enumerate epidermal LC before and after treatment. PUVA was a highly effective mode of treatment and cleared all treated hands. UVB was better than no treatment but the dermatitis did not clear in any patient. The number of epidermal LC was increased in lesional palmar skin in both allergic contact dermatitis, irritant contact dermatitis and hyperkeratotic dermatitis of the palms.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

长期存在的手足皮肤病,如掌跖脓疱病(PPP)和慢性湿疹性手部皮炎,严重影响患者的生活质量。PPP的病因不明,且该病通常对治疗反应不佳。对PPP进行研究的目的是确定甲状腺疾病的患病率,并评估维甲酸、补骨脂素光化学疗法(PUVA)以及二者联合治疗的相对优势。此外,还对治疗前后皮损处的表皮朗格汉斯细胞(LC)进行了定量分析。与正常人和银屑病患者相比,一组PPP患者中甲状腺疾病的患病率显著升高。甲状腺功能减退和亢进均有发现。此外,PPP患者中针对甲状腺抗原的循环自身抗体比对照组更为常见。在一组新的、更大规模的PPP患者中进一步检查了甲状腺状况,包括对那些有甲状腺抗体或亚临床甲状腺功能障碍的患者进行了为期四年的随访检查。当将该PPP组与来自同一城市的年龄和性别匹配的对照人群样本进行比较时,甲状腺疾病患病率增加得到了证实。一些患者还表现出胃部自身免疫的生化证据。94%的PPP患者在皮肤病发作时吸烟,而对照组中这一比例为33%。招募了对治疗耐药的PPP患者进行一项随机、双盲和安慰剂对照试验。维甲酸与PUVA联合治疗比维甲酸或PUVA单一疗法更有效。后两者疗效相当。维甲酸经常引发副作用。随访检查显示复发率很高。利用免疫过氧化物酶技术,用针对Leu 6和HLA-DR抗原的单克隆抗体使表皮LC可视化。其数量在皮损处增加。维甲酸治疗后HLA-DR阳性LC数量减少,而维甲酸 + PUVA联合治疗后数量恢复正常。慢性湿疹性手部皮炎是一个常见的临床难题。这些研究旨在评估PUVA和UVB光疗对顽固性皮损患者的疗效,并在治疗前后对表皮LC进行计数。PUVA是一种高效的治疗方式,所有接受治疗的手部皮损均消退。UVB比不治疗要好,但没有任何患者的皮炎消退。在过敏性接触性皮炎、刺激性接触性皮炎和掌部角化过度性皮炎的皮损掌部皮肤中,表皮LC数量均增加。(摘要截选至400词)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验